Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novavax Inc (NVAX)

Novavax Inc (NVAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,243,831
  • Shares Outstanding, K 74,094
  • Annual Sales, $ 475,600 K
  • Annual Income, $ -418,260 K
  • 60-Month Beta 1.56
  • Price/Sales 30.28
  • Price/Cash Flow N/A
  • Price/Book 12.90
Trade NVAX with:

Options Overview

Details
  • Implied Volatility 62.55%
  • Historical Volatility 85.49%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 173.44% on 07/20/20
  • IV Low 62.55% on 06/24/21
  • Put/Call Vol Ratio 0.42
  • Today's Volume 13,395
  • Volume Avg (30-Day) 21,513
  • Put/Call OI Ratio 0.82
  • Today's Open Interest 188,118
  • Open Int (30-Day) 173,558

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -3.76
  • Number of Estimates 4
  • High Estimate -1.29
  • Low Estimate -6.51
  • Prior Year -0.30
  • Growth Rate Est. (year over year) -1,153.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
141.05 +36.46%
on 06/02/21
229.50 -16.13%
on 06/14/21
+46.56 (+31.91%)
since 05/24/21
3-Month
117.12 +64.34%
on 05/13/21
263.67 -27.00%
on 04/27/21
-7.76 (-3.88%)
since 03/24/21
52-Week
70.31 +173.76%
on 06/26/20
331.68 -41.97%
on 02/09/21
+114.98 (+148.36%)
since 06/24/20

Most Recent Stories

More News
Novavax (NVAX) Gains But Lags Market: What You Should Know

In the latest trading session, Novavax (NVAX) closed at $192.48, marking a +0.12% move from the previous day.

NVAX : 192.48 (+0.12%)
Novavax (NVAX) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Novavax (NVAX) closed at $192.24, marking a -1.1% move from the previous day.

NVAX : 192.48 (+0.12%)
Minister Champagne marks the completion of construction of the Biologics Manufacturing Centre in Montréal

COMTEX_388669905/2669/2021-06-22T09:53:55

NVAX : 192.48 (+0.12%)
Novavax to Participate in Fireside Chat at SVB Leerink CybeRx Series: Vaccine Forum

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat during...

NVAX : 192.48 (+0.12%)
Thinking about trading options or stock in Sunrun, Trade Desk, Novavax, Ford, or Bank of America?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RUN, TTD, NVAX, F, and BAC.

NVAX : 192.48 (+0.12%)
RUN : 52.84 (-5.39%)
TTD : 75.88 (+16.04%)
BAC : 40.83 (+1.57%)
F : 15.26 (-1.04%)
Novavax to Participate in National Vaccine Advisory Committee Meeting

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that , M.D., President, Research and Development,...

NVAX : 192.48 (+0.12%)
Biotech Stock Roundup: SAGE Declines on Data, Regulatory Updates From VRTX, ITOS

The biotech sector was in focus last week with regulatory updates from Sage (SAGE) and Vertex (VRTX), among others.

REGN : 544.45 (+2.77%)
GSK : 39.70 (-0.38%)
BIIB : 349.16 (-6.11%)
VRTX : 191.94 (+2.36%)
NVAX : 192.48 (+0.12%)
SAGE : 57.01 (+1.12%)
ITOS : 23.81 (+2.67%)
Novavax's (NVAX) COVID-19 Vaccine Shows 90% Efficacy in US Study

Novavax's (NVAX) COVID-19 vaccine candidate, NVX-CoV2373, shows an overall efficacy of 90% in the phase III PREVENT-19 study in the United States and Mexico.

JNJ : 163.37 (+0.46%)
MRNA : 220.14 (+3.82%)
NVAX : 192.48 (+0.12%)
BNTX : 227.79 (-0.75%)
Thinking about trading options or stock in Draftkings, GameStop, Freeport-McMoRan, Novavax, or Cleveland-Cliffs?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for DKNG, GME, FCX, NVAX, and CLF.

DKNG : 51.06 (+1.05%)
NVAX : 192.48 (+0.12%)
CLF : 21.81 (+3.17%)
FCX : 37.52 (+0.91%)
GME : 212.31 (-3.21%)
Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced data from the first co-administration study of...

NVAX : 192.48 (+0.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

NOVAVAX INC is a specialty biopharmaceutical company engaged in the research, development and commercialization of proprietary products focused on women's health and infectious diseases. Their technology platforms involve the use of proprietary, microscopic, organized, non-phospholipid structures as...

See More

Key Turning Points

3rd Resistance Point 206.32
2nd Resistance Point 202.16
1st Resistance Point 197.32
Last Price 192.48
1st Support Level 188.32
2nd Support Level 184.16
3rd Support Level 179.32

See More

52-Week High 331.68
Fibonacci 61.8% 231.84
Fibonacci 50% 201.00
Last Price 192.48
Fibonacci 38.2% 170.15
52-Week Low 70.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar